Glenn Larsen
Direktor/Vorstandsmitglied bei ANIKA THERAPEUTICS, INC.
Vermögen: 775 662 $ am 30.04.2024
Aktive Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Cheryl Blanchard | M | 59 | 6 Jahre | |
| John Henneman | M | 62 | 4 Jahre | |
| Russell Herndon | M | 65 |
Hydra Biosciences, Inc.
 Hydra Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Hydra Biosciences, Inc. develops pharmaceutical products. It is focused in major therapeutic areas, which include pain, inflammation, renal, anxiety, and pulmonary diseases. The company was founded by Laurie Bartlett Keating, Dean Y. Li, David E. Clapham, and Mark T. Keating in 2001 and is headquartered in Belmont, MA. | 18 Jahre |
| Jeffery Thompson | M | 58 | 13 Jahre | |
| Susan Vogt | F | 70 | 6 Jahre | |
| Ben Wolozin | M | - |
Aquinnah Pharmaceuticals, Inc.
 Aquinnah Pharmaceuticals, Inc. BiotechnologyHealth Technology Aquinnah Pharmaceuticals, Inc. restores the health of people with ALS, Alzheimer?s disease and other neurodegenerative diseases. The company was founded by Glenn Larsen and Ben Wolozin in 2014 and is headquartered in Cambridge, MA. | 10 Jahre |
| Mark Namaroff | M | 60 | - | |
| Michael Levitz | M | 50 | 4 Jahre | |
| Gary Fischetti | M | 63 | 1 Jahre | |
| Stephen Richard | M | 61 | 4 Jahre | |
| Sheryl Conley | F | 63 | 3 Jahre | |
| Mira Leiwant | F | - | 5 Jahre | |
| David Colleran | M | 52 | 4 Jahre | |
| Lisa Funiciello | F | - | 2 Jahre | |
| Jonathan Lanfear | M | 55 |
Aquinnah Pharmaceuticals, Inc.
Aquinnah Pharmaceuticals, Inc. BiotechnologyHealth Technology Aquinnah Pharmaceuticals, Inc. restores the health of people with ALS, Alzheimer?s disease and other neurodegenerative diseases. The company was founded by Glenn Larsen and Ben Wolozin in 2014 and is headquartered in Cambridge, MA. | - |
| Ian McLeod | M | - | 3 Jahre | |
| Duane Burnett | M | - |
Aquinnah Pharmaceuticals, Inc.
Aquinnah Pharmaceuticals, Inc. BiotechnologyHealth Technology Aquinnah Pharmaceuticals, Inc. restores the health of people with ALS, Alzheimer?s disease and other neurodegenerative diseases. The company was founded by Glenn Larsen and Ben Wolozin in 2014 and is headquartered in Cambridge, MA. | - |
| Bob Carpenter | M | - |
Aquinnah Pharmaceuticals, Inc.
Aquinnah Pharmaceuticals, Inc. BiotechnologyHealth Technology Aquinnah Pharmaceuticals, Inc. restores the health of people with ALS, Alzheimer?s disease and other neurodegenerative diseases. The company was founded by Glenn Larsen and Ben Wolozin in 2014 and is headquartered in Cambridge, MA. | - |
| James Chase | M | - | 6 Jahre | |
| Charles Kunsch | M | - |
Aquinnah Pharmaceuticals, Inc.
Aquinnah Pharmaceuticals, Inc. BiotechnologyHealth Technology Aquinnah Pharmaceuticals, Inc. restores the health of people with ALS, Alzheimer?s disease and other neurodegenerative diseases. The company was founded by Glenn Larsen and Ben Wolozin in 2014 and is headquartered in Cambridge, MA. | 7 Jahre |
| Steven Ek | M | - | 4 Jahre | |
| Anne Nunes | F | 55 | 3 Jahre |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Sylvia Cheung | F | 50 | 15 Jahre | |
| Pieter Muntendam | M | 65 |
SpringLeaf Therapeutics, Inc.
 SpringLeaf Therapeutics, Inc. Drugstore ChainsRetail Trade SpringLeaf Therapeutics, Inc. is creating innovative therapeutic modalities to address serious disease and elevate the quality of care for patients. SpringLeaf's technology is based on the convergence of materials science and medicine and is designed to enable and differentiate therapeutics. SpringLeaf was founded based on breakthrough science at MIT and is backed by leading investors including Excel Venture Management, Flybridge Capital Partners, North Bridge Venture Partners and SR One. | - |
| Charles Sherwood | M | 76 | 20 Jahre | |
| Thomas Joseph Burke | M | - |
Hydra Biosciences, Inc.
Hydra Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Hydra Biosciences, Inc. develops pharmaceutical products. It is focused in major therapeutic areas, which include pain, inflammation, renal, anxiety, and pulmonary diseases. The company was founded by Laurie Bartlett Keating, Dean Y. Li, David E. Clapham, and Mark T. Keating in 2001 and is headquartered in Belmont, MA. | 11 Jahre |
| Joseph G. Darling | M | 66 | 3 Jahre | |
| Joseph Bower | M | 85 | 28 Jahre | |
| Steven J. Chartier | M | 55 | 1 Jahre | |
| Garen Bohlin | M | 76 |
SpringLeaf Therapeutics, Inc.
SpringLeaf Therapeutics, Inc. Drugstore ChainsRetail Trade SpringLeaf Therapeutics, Inc. is creating innovative therapeutic modalities to address serious disease and elevate the quality of care for patients. SpringLeaf's technology is based on the convergence of materials science and medicine and is designed to enable and differentiate therapeutics. SpringLeaf was founded based on breakthrough science at MIT and is backed by leading investors including Excel Venture Management, Flybridge Capital Partners, North Bridge Venture Partners and SR One. | 4 Jahre |
| John C. Moran | M | 71 | 9 Jahre | |
| Steven E. Wheeler | M | 77 | 26 Jahre | |
| Raymond J. Land | M | 79 | 16 Jahre | |
| Dana M. Alexander | M | 47 | 2 Jahre | |
| Robert Richard | M | - | 1 Jahre | |
| Charles Sherwood | M | - | - | |
| Alexei Goraltchouk | M | - | 3 Jahre | |
| Thomas Finnerty | M | 66 | - | |
| Ellen MacKenzie | F | - | - | |
| Jean Bjerke | F | - | 1 Jahre | |
| Richard Hague | M | 63 | 4 Jahre | |
| Christopher Ranjitkar | M | - | 1 Jahre | |
| Stephen R. Mascioli | M | 69 | 1 Jahre | |
| Stephen Garbacz | M | 65 | 2 Jahre | |
| Neil J. Hayward | M | - |
Hydra Biosciences, Inc.
Hydra Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Hydra Biosciences, Inc. develops pharmaceutical products. It is focused in major therapeutic areas, which include pain, inflammation, renal, anxiety, and pulmonary diseases. The company was founded by Laurie Bartlett Keating, Dean Y. Li, David E. Clapham, and Mark T. Keating in 2001 and is headquartered in Belmont, MA. | 7 Jahre |
| Francesco J. Luppino | M | 55 | 2 Jahre | |
| Edward S. Ahn | M | 51 | 5 Jahre | |
| Kurt Graves | M | 56 |
SpringLeaf Therapeutics, Inc.
SpringLeaf Therapeutics, Inc. Drugstore ChainsRetail Trade SpringLeaf Therapeutics, Inc. is creating innovative therapeutic modalities to address serious disease and elevate the quality of care for patients. SpringLeaf's technology is based on the convergence of materials science and medicine and is designed to enable and differentiate therapeutics. SpringLeaf was founded based on breakthrough science at MIT and is backed by leading investors including Excel Venture Management, Flybridge Capital Partners, North Bridge Venture Partners and SR One. | 2 Jahre |
| Edward Gaj | M | 67 | 4 Jahre | |
| James Loerop | M | 60 | - |
Statistik
| Land | Beziehungen | % des Gesamten |
|---|---|---|
| Vereinigte Staaten | 50 | 100,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Glenn Larsen
- Persönliches Netzwerk
